
Genetics 🧬, Molecular Ecology 🌱🐄🐟🐓🐖and Evolution 👨🏻🔬 @TecdeMonterrey
- Tweets67
- Following70
- Followers14
- Likes345

ALT The quest to fundamentally reverse human aging has reached a historic milestone with the FDA officially greenlighting the first human clinical trial for a gene therapy designed to reverse biological age at the cellular level. This groundbreaking treatment is spearheaded by Life Biosciences, a biotech company co-founded by Harvard genetics professor David Sinclair, and utilizes a technique known as partial epigenetic reprogramming. The therapy acts as a "software reset" for the body by delivering a specific cocktail of three genes that modify chemical tags on DNA to make older cells function as if they were young again. The scientific foundation for this trial is based on staggering laboratory results where Sinclair's team used this reprogramming technique to reverse the biological age of animal cells by up to 75 percent. Rather than merely slowing aging, the therapy actively restored youthful functions, such as regenerating damaged optic nerves and curing blindness.












































